Cargando…

A rare presentation of central pontine myelinolysis secondary to hyperglycaemia

BACKGROUND: Central pontine myelinolysis (CPM) is a rare demyelinating disorder caused by the loss of myelin in the center of the basis pontis. CPM typically occurs with rapid correction of severe chronic hyponatremia and subsequent disturbances in serum osmolality. Although hyperglycaemia is recogn...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Wen-Ping, Wang, Ying-Di, Gao, Song, Wang, Yi-Fan, Li, Da-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170667/
https://www.ncbi.nlm.nih.gov/pubmed/37165361
http://dx.doi.org/10.1186/s12902-023-01361-y
_version_ 1785039270816251904
author Sun, Wen-Ping
Wang, Ying-Di
Gao, Song
Wang, Yi-Fan
Li, Da-Wei
author_facet Sun, Wen-Ping
Wang, Ying-Di
Gao, Song
Wang, Yi-Fan
Li, Da-Wei
author_sort Sun, Wen-Ping
collection PubMed
description BACKGROUND: Central pontine myelinolysis (CPM) is a rare demyelinating disorder caused by the loss of myelin in the center of the basis pontis. CPM typically occurs with rapid correction of severe chronic hyponatremia and subsequent disturbances in serum osmolality. Although hyperglycaemia is recognized as a pathogenetic factor in serum osmolality fluctuations, CPM is rarely seen in the context of diabetes. CASE PRESENTATION: A 66-year-old Chinese male presented with a history of gait imbalance, mild slurred speech and dysphagia for two weeks. MRI showed the mass lesions in the brainstem, and laboratory examinations showed high blood glucose and HbA1c, as well as increased serum osmolality. The patient was diagnosed with CPM secondary to hyperosmolar hyperglyceamia and received insulin treatment as well as supportive therapy. After six weeks of followup, the patient had fully recovered to a normal state. CONCLUSION: CPM is a potentially fatal neurological condition and can occur in uncontrolled diabetes mellitus. Early diagnosis and timely treatment are crucial for improving the prognosis.
format Online
Article
Text
id pubmed-10170667
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101706672023-05-11 A rare presentation of central pontine myelinolysis secondary to hyperglycaemia Sun, Wen-Ping Wang, Ying-Di Gao, Song Wang, Yi-Fan Li, Da-Wei BMC Endocr Disord Case Report BACKGROUND: Central pontine myelinolysis (CPM) is a rare demyelinating disorder caused by the loss of myelin in the center of the basis pontis. CPM typically occurs with rapid correction of severe chronic hyponatremia and subsequent disturbances in serum osmolality. Although hyperglycaemia is recognized as a pathogenetic factor in serum osmolality fluctuations, CPM is rarely seen in the context of diabetes. CASE PRESENTATION: A 66-year-old Chinese male presented with a history of gait imbalance, mild slurred speech and dysphagia for two weeks. MRI showed the mass lesions in the brainstem, and laboratory examinations showed high blood glucose and HbA1c, as well as increased serum osmolality. The patient was diagnosed with CPM secondary to hyperosmolar hyperglyceamia and received insulin treatment as well as supportive therapy. After six weeks of followup, the patient had fully recovered to a normal state. CONCLUSION: CPM is a potentially fatal neurological condition and can occur in uncontrolled diabetes mellitus. Early diagnosis and timely treatment are crucial for improving the prognosis. BioMed Central 2023-05-10 /pmc/articles/PMC10170667/ /pubmed/37165361 http://dx.doi.org/10.1186/s12902-023-01361-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Sun, Wen-Ping
Wang, Ying-Di
Gao, Song
Wang, Yi-Fan
Li, Da-Wei
A rare presentation of central pontine myelinolysis secondary to hyperglycaemia
title A rare presentation of central pontine myelinolysis secondary to hyperglycaemia
title_full A rare presentation of central pontine myelinolysis secondary to hyperglycaemia
title_fullStr A rare presentation of central pontine myelinolysis secondary to hyperglycaemia
title_full_unstemmed A rare presentation of central pontine myelinolysis secondary to hyperglycaemia
title_short A rare presentation of central pontine myelinolysis secondary to hyperglycaemia
title_sort rare presentation of central pontine myelinolysis secondary to hyperglycaemia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170667/
https://www.ncbi.nlm.nih.gov/pubmed/37165361
http://dx.doi.org/10.1186/s12902-023-01361-y
work_keys_str_mv AT sunwenping ararepresentationofcentralpontinemyelinolysissecondarytohyperglycaemia
AT wangyingdi ararepresentationofcentralpontinemyelinolysissecondarytohyperglycaemia
AT gaosong ararepresentationofcentralpontinemyelinolysissecondarytohyperglycaemia
AT wangyifan ararepresentationofcentralpontinemyelinolysissecondarytohyperglycaemia
AT lidawei ararepresentationofcentralpontinemyelinolysissecondarytohyperglycaemia
AT sunwenping rarepresentationofcentralpontinemyelinolysissecondarytohyperglycaemia
AT wangyingdi rarepresentationofcentralpontinemyelinolysissecondarytohyperglycaemia
AT gaosong rarepresentationofcentralpontinemyelinolysissecondarytohyperglycaemia
AT wangyifan rarepresentationofcentralpontinemyelinolysissecondarytohyperglycaemia
AT lidawei rarepresentationofcentralpontinemyelinolysissecondarytohyperglycaemia